Finance

Lists
Why is 524412 up 4,10%?
Dive Deeper
524412:BOM
Aarey Drugs and Pharmaceuticals Ltd
112,90 INR
+4,10%
(+4,45) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524412...
Open
107,55 INR
High
113,50 INR
Low
105,40 INR
Mkt. cap
3,61 млд
Avg. vol.
12,55 миң
Volume
5,29 миң
P/E ratio
88,74
52-wk high
113,50 INR
52-wk low
50,40 INR
EPS
1,27 INR
No. of employees
0
Open
107,55 INR
High
113,50 INR
Low
105,40 INR
Mkt. cap
3,61 млд
Avg. vol.
12,55 миң
Volume
5,29 миң
P/E ratio
88,74
52-wk high
113,50 INR
52-wk low
50,40 INR
EPS
1,27 INR
No. of employees
0
News stories
From web sources and news partners
About Aarey Drugs and Pharmaceuticals Ltd
CEO-
Employees0
Founded1990
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
841,62 млн
964,26 млн
1,89 млд
446,26 млн
Cost of goods sold
804,83 млн
967,96 млн
1,79 млд
421,54 млн
Cost of revenue
804,83 млн
967,96 млн
1,79 млд
421,54 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,08 млн
4,25 млн
-3,60 млн
6,89 млн
Operating expense
17,29 млн
19,69 млн
50,37 млн
19,96 млн
Total operating expenses
822,12 млн
987,65 млн
1,85 млд
441,50 млн
Operating income
19,50 млн
-23,39 млн
49,56 млн
4,75 млн
Other non operating income
7,93 млн
41,82 млн
-72,35 млн
17,15 млн
EBT including unusual items
14,82 млн
9,24 млн
12,80 млн
5,16 млн
EBT excluding unusual items
14,82 млн
9,24 млн
12,80 млн
5,16 млн
Income tax expense
4,58 млн
3,54 млн
2,77 млн
-5,08 млн
Effective tax rate
30,92%
38,35%
21,66%
-98,55%
Other operating expenses
4,29 млн
7,18 млн
45,51 млн
4,57 млн
Net income
10,24 млн
5,70 млн
10,03 млн
10,24 млн
Net profit margin
1,22%
0,59%
0,53%
2,29%
Earnings per share
-
-
-
-
Interest and investment income
-
-
46,30 млн
-
Interest expense
-12,60 млн
-9,19 млн
-10,76 млн
-16,74 млн
Net interest expenses
-12,60 млн
-9,19 млн
35,54 млн
-16,74 млн
Depreciation and amortization charges
6,93 млн
8,26 млн
8,46 млн
8,50 млн
EBITDA
25,40 млн
-18,53 млн
56,69 млн
11,88 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору